Testimonials

Vector Consulting Group is an 18-year-old homegrown Indian management consulting company. They offer unique solutions to chronic and ‘wicked’ problems in areas of supply chain, operations, sales &amp; distribution, R&amp;D, NPD, retail, and CAPEX projects. With their unique engagement model – the ‘skin-in-the-game’ model, they work with the client to implement the solution and link a part of our remuneration to the results that we deliver for our clients. With a team of 200+ consultants, they have implemented 300+ assignments for clients across India, Africa, the Middle East and Southeast Asia.&nbsp; Across these 300+ projects, they have delivered significant results for their clients. Some of their past clients are L&amp;T, Tata Motors CV, Ashok Leyland, International Tractors, Royal Enfield, Bajaj Electricals, Godrej group, Ajanta Pharma, Lupin Labs, Trent, Raymonds, Arvind Fashion, Blackberrys, Pratibha Syntex, and more.They have a strategic tie-up with TIS Inc., a $4.00 Bn Japanese company. Last year, they opened offices in Indonesia and the US. &nbsp;

By Vector Consulting Group

The pharma alchemy

India’s pharmaceutical sector stands as a global powerhouse, commanding 20% of the world’s generic drug market and 60% of the vaccine market. Yet, beneath this remarkable growth lies a pressing challenge: sustaining profitability by improving efficiency while also enhancing market responsiveness and ensuring exceptional regulatory compliance.Despite strong margins, many pharma firms face persistent inefficiencies—from underutilised capacities and skewed inventories to slow R&amp;D pipelines and quality-related vulnerabilities. As U.S. market dynamics evolve, Indian companies must rethink operations to stay competitive.This compilation reveals how forward-thinking firms redefined success by addressing operational constraints. Discover how they unlocked 25%-30% additional plant capacity, doubled R&amp;D project speeds, and reduced inventory by 25%—all while enhancing quality and ensuring compliance.Explore strategies that transform pharma operations from good to world-class. The future of India’s pharma industry lies in mastering operational agility—and this is your guide to leading that transformation.

First Edition

India’s pharmaceutical sector stands as a global powerhouse, commanding 20% of the world’s generic drug market and 60% of the vaccine market. Yet, beneath this remarkable growth lies a pressing challenge: sustaining profitability by improving efficiency while also enhancing market responsiveness and ensuring exceptional regulatory compliance.Despite strong margins, many pharma firms face persistent inefficiencies—from underutilised capacities and skewed inventories to slow R&amp;D pipelines and quality-related vulnerabilities. As U.S. market dynamics evolve, Indian companies must rethink operations to stay competitive.This compilation reveals how forward-thinking firms redefined success by addressing operational constraints. Discover how they unlocked 25%-30% additional plant capacity, doubled R&amp;D project speeds, and reduced inventory by 25%—all while enhancing quality and ensuring compliance.Explore strategies that transform pharma operations from good to world-class. The future of India’s pharma industry lies in mastering operational agility—and this is your guide to leading that transformation.&nbsp; &nbsp;

Let's Empower Growth